These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1126966)

  • 1. Persistence of measles antibody after immunization.
    Domorázková E; Drevo M
    J Biol Stand; 1975; 3(2):225-30. PubMed ID: 1126966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 3. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
    Whittle HC; Campbell H; Rahman S; Armstrong JR
    Lancet; 1990 Oct; 336(8722):1046-8. PubMed ID: 1977029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic response and reactions to vaccination in children vaccinated against measles. III. Persistence of measles antibodies in children vaccinated in 1972].
    Kańtoch M; Naruszewicz-Lesiuk D; Polna I; Lityńska J
    Przegl Epidemiol; 1976; 30(2):235-41. PubMed ID: 945592
    [No Abstract]   [Full Text] [Related]  

  • 6. Measles revaccination. Persistence and degree of antibody titer by type of immune response.
    Deseda-Tous J; Cherry JD; Spencer MJ; Welliver RC; Boyer KM; Dudley JP; Zahradnik JM; Krause PJ; Walbergh EW
    Am J Dis Child; 1978 Mar; 132(3):287-90. PubMed ID: 629246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.
    Swartz TA; Klingberg W; Klingberg MA
    Infection; 1974; 2(3):115-7. PubMed ID: 4606362
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
    Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.
    Aleksandrowicz J; Polna I; Sadowski W
    Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of a trial of an erythrocyte measles diagnostic agent in public health institutions].
    Polzik TP; Kashkina GB; Andrianova DP; Bol'shakova SL; Petrova MA
    Tr Inst Im Pastera; 1981; 56():112-4. PubMed ID: 6764964
    [No Abstract]   [Full Text] [Related]  

  • 13. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 15. Seroepidemiology of measles in Delhi: implications for age of vaccination.
    Khare S; Dutta A; Kumari S; Basu RN
    Indian J Pediatr; 1987; 54(5):711-5. PubMed ID: 3501410
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles immunization: new recommendation.
    Krugman S
    JAMA; 1977 Jan; 237(4):366. PubMed ID: 576171
    [No Abstract]   [Full Text] [Related]  

  • 17. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitivity of immune adherence haemagglutination in detection of measles antibody in vaccinated and naturally immune individuals.
    Rapicetta M; D'Ambrosio E; Rozera C; Balducci L; Magliola E
    J Biol Stand; 1981 Oct; 9(4):373-8. PubMed ID: 7320020
    [No Abstract]   [Full Text] [Related]  

  • 20. Measles antibody levels in children of rural and urban areas of Nigeria following vaccination campaign.
    Eghafona NO; Odama LE; Emejuaiwe SO; Obineche EN; Tafida DS
    Epidemiol Infect; 1987 Aug; 99(1):85-9. PubMed ID: 3609176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.